Terms: = Ovarian cancer AND FBXW7, AGO, 55294, ENSG00000109670, FLJ11071, SEL-10, CDC4, FBXW6, SEL10, FBW7, DKFZp686F23254, FBX30 AND Treatment
223 results:
1. Laparoscopic transabdominal-sacrococcygeal approach for resection of Altman type III sacrococcygeal teratoma in adult women: A case report.
Zhong Q; Zhang Q; Xiao Z; Zhang H
Medicine (Baltimore); 2024 Apr; 103(17):e37887. PubMed ID: 38669424
[TBL] [Abstract] [Full Text] [Related]
2. [Recurrent Breast cancer with Bone Metastasis Effectively Treated with Abemaciclib plus Endocrine Therapy-A Case Report].
Adachi K; Nagae J; Kubota H; Suzuki S; Hirano T; Sakurai K
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1845-1847. PubMed ID: 38303227
[TBL] [Abstract] [Full Text] [Related]
3. [News in breast oncology genetics for female and male population].
Taris N; Luporsi E; Osada M; Thiblet M; Mathelin C
Gynecol Obstet Fertil Senol; 2024 Mar; 52(3):149-157. PubMed ID: 38190969
[TBL] [Abstract] [Full Text] [Related]
4. Fibroblast Growth Factor Receptors and Ligands in Context of Bevacizumab Response in ovarian Carcinoma: An Exploratory Analysis of ago-OVAR11/ICON-7.
Heublein S; Pfisterer J; du Bois A; Anglesio M; Aminossadati B; Bhatti I; Sehouli J; Wimberger P; Schochter F; Hilpert F; Hillemanns P; Kalder M; Schroeder W; Mahner S; Burges A; Canzler U; Gropp-Meier M; Jackisch C; Harter P; Kommoss S; Marmé F
Lab Invest; 2024 Apr; 104(4):100321. PubMed ID: 38154497
[TBL] [Abstract] [Full Text] [Related]
5. ago-OVAR 28/ENGOT-ov57. Niraparib alone versus niraparib in combination with bevacizumab in patients with carboplatin-taxane-based chemotherapy in advanced ovarian cancer: a multicenter randomized phase III trial.
Heitz F; Marth C; Henry S; Reuss A; Cibula D; Gaba Garcia L; Colombo N; Schmalfeld B; de Gregorio N; Wimberger P; Hasenburg A; Sehouli J; Gropp-Meier M; Schouten PC; Hahnen E; Hauke J; Polleis S; Harter P
Int J Gynecol Cancer; 2023 Dec; 33(12):1966-1969. PubMed ID: 37935524
[TBL] [Abstract] [Full Text] [Related]
6. [Surgery of peritoneal surface malignancies - surgical cytoreduction and hyperthermic intraperitoneal chemotherapy].
Huszty G; Bihari L; Gráf L; Szijártó A; Máté S
Magy Onkol; 2023 Sep; 67(3):247-258. PubMed ID: 37768120
[TBL] [Abstract] [Full Text] [Related]
7. Endometrioid adenocarcinoma of the rectovaginal septum: A case report.
Mu Q; Wang C; Liu H; Xu Y; Luan S; Xia B
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Jun; 48(6):941-946. PubMed ID: 37587081
[TBL] [Abstract] [Full Text] [Related]
8. Unilateral ovarian recurrence 5 years after hysterectomy for microinvasive squamous cervical cancer stage IA1: a rare case report.
Tong L; Wu L
BMC Womens Health; 2023 Jul; 23(1):350. PubMed ID: 37393247
[TBL] [Abstract] [Full Text] [Related]
9. The highs and lows of serous ovarian cancer.
Grisham RN; Manning-Geist BL; Chui MH
Cancer; 2023 Sep; 129(17):2613-2620. PubMed ID: 37366225
[TBL] [Abstract] [Full Text] [Related]
10. Cerebrospinal fluid-dissemination of a ovarian clear cell carcinoma: A leptomeningial carcinomatosis with diagnostic challenges.
Koyuncuer A; Varol E; Serarslan Yağcioğlu B; Bükte Y; Sakcı Z
Diagn Cytopathol; 2023 Aug; 51(8):E228-E231. PubMed ID: 37071049
[TBL] [Abstract] [Full Text] [Related]
11. Quality of therapy in early ovarian cancer: results of the quality assurance program of the ago Study Group.
Wimberger P; Pfisterer J; du Bois A; Hilpert F; Kerkmann M; Sehouli J; Mahner S; de Gregorio N; Hanker L; Heitz F; Marmé F; Woelber L; Holtmann L; Elser G; Harter P;
Int J Gynecol Cancer; 2023 Jul; 33(7):1083-1089. PubMed ID: 37001891
[TBL] [Abstract] [Full Text] [Related]
12. treatment and survival of patients with malignant ovarian sex cord-stromal cell tumours: An analysis of the Arbeitsgemeinschaft für Gynäkologische Onkologie (ago) study group CORSETT database.
Klar M; Plett H; Harter P; Heitz F; Kommoss S; Hartkopf AD; Grube M; Roser E; Sehouli J; Braicu I; Czogalla B; Burges A; Bossart M; Hasanov MF; Link T; Staebler A; Mayr D; Buderath P; Hasenburg A
J Surg Oncol; 2023 Jul; 128(1):111-118. PubMed ID: 36975108
[TBL] [Abstract] [Full Text] [Related]
13. Statement of the ago Kommission Ovar, ago Study Group, NOGGO, ago Austria, Swiss ago, BGOG, CEEGOG, GEICO, and SFOG regarding the use of hyperthermic intraperitoneal chemotherapy (HIPEC) in epithelial ovarian cancer.
Harter P; Bogner G; Chiva L; Cibula D; Concin N; Fotopoulou C; Gonzalez-Martin A; Guyon F; Heinzelmann-Schwarz V; Kridelka F; Mahner S; Marmé F; Marth C; Morice P; Novák Z; Papadia A; Ray-Coquard I; Redecha M; Redondo A; Schwameis R; Sehouli J; Undurraga M; Van Gorp T; Vergote I
Bull Cancer; 2024 Mar; 111(3):277-284. PubMed ID: 36967330
[TBL] [Abstract] [Full Text] [Related]
14. Endometrioid adenofibroma of ovary: A case report and review of literature.
Tong HC; Li YC; Li LY; Xu HT; Ma S; Zhang WL; Wildes T; Yang LH; Wang E
Medicine (Baltimore); 2023 Feb; 102(8):e32965. PubMed ID: 36827035
[TBL] [Abstract] [Full Text] [Related]
15. [A Case of Solitary Liver Metastasis of Low-Grade Endometrial Stromal Sarcoma 31 Years after Resection of Primary Lesion].
Nakama Y; Shimamatsu K; Morita T; Kawano R; Sakata K; Sueyoshi S; Murakami N; Yomoda T; Sasaki S; Taniwaki S; Taniguchi H; Yoshinaga Y; Mikasa K; Takagi K; Yoshida A
Gan To Kagaku Ryoho; 2022 Dec; 49(13):1777-1779. PubMed ID: 36732996
[TBL] [Abstract] [Full Text] [Related]
16. [Different radical surgical treatment of cervical cancer based on the histopathological characteristics of the tumour].
Lintner B
Magy Onkol; 2022 Dec; 66(4):289-293. PubMed ID: 36602248
[TBL] [Abstract] [Full Text] [Related]
17. ECPPF (E2F1, CCNA2, POLE, PPP2R1A, fbxw7) stratification: Profiling high-risk subtypes of histomorphologically low-risk and treatment-insensitive endometrioid endometrial cancer.
Gonzalez-Bosquet J; Weroha SJ; Bakkum-Gamez JN; Weaver AL; McGree ME; Dowdy SC; Famuyide AO; Kipp BR; Halling KC; Yadav S; Couch FJ; Podratz KC
PLoS One; 2022; 17(12):e0278408. PubMed ID: 36454788
[TBL] [Abstract] [Full Text] [Related]
18. RAD51 paralogs: Expanding roles in replication stress responses and repair.
Bhattacharya D; Sahoo S; Nagraj T; Dixit S; Dwivedi HK; Nagaraju G
Curr Opin Pharmacol; 2022 Dec; 67():102313. PubMed ID: 36343481
[TBL] [Abstract] [Full Text] [Related]
19. Optimal treatment Duration of Bevacizumab as Front-Line Therapy for Advanced ovarian cancer: ago-OVAR 17 BOOST/GINECO OV118/ENGOT Ov-15 Open-Label Randomized Phase III Trial.
Pfisterer J; Joly F; Kristensen G; Rau J; Mahner S; Pautier P; El-Balat A; Kurtz JE; Canzler U; Sehouli J; Heubner ML; Hartkopf AD; Baumann K; Hasenburg A; Hanker LC; Belau A; Schmalfeldt B; Denschlag D; Park-Simon TW; Selle F; Jackisch C; Burges A; Lück HJ; Emons G; Meier W; Gropp-Meier M; Schröder W; de Gregorio N; Hilpert F; Harter P
J Clin Oncol; 2023 Feb; 41(4):893-902. PubMed ID: 36332161
[TBL] [Abstract] [Full Text] [Related]
20. Health influence of SARS-CoV-2 (COVID-19) on cancer: a review.
Parise R; Li YE; Nadar RM; Ramesh S; Ren J; Govindarajulu MY; Moore T; Dhanasekaran M
Acta Biochim Biophys Sin (Shanghai); 2022 Oct; 54(10):1395-1405. PubMed ID: 36269132
[TBL] [Abstract] [Full Text] [Related]
[Next]
